Middletown, DE -- (SBWIRE) -- 09/20/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: TASER International, Inc. (NASDAQ:TASR), Canadian Solar Inc. (NASDAQ:CSIQ), Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
TASER International, Inc. (NASDAQ:TASR) was a volume gainer of 1.69 million shares and the average volume of the stock remained 1.38 million shares. The stock opened the session at $14.15 and finished at the end of the day at $14.26 and the stock escalated +1.17%.The market capitalization of the stock remained 727.92 million. The half-yearly trend of the stock remained positive +81.19%. TASER International, Inc. engages in the development, manufacture, and sale of conducted electrical weapons (CEWs) for use in law enforcement, federal, military, corrections, private security, and personal defense markets worldwide. Its CEWs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system.
For How Long TASR will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Canadian Solar Inc. (NASDAQ:CSIQ) exchanged 1.65 million shares and the average volume remained 2.76 million shares. The stock closed the session at $14.86 with the gain of +1.71%. Tracking three months and 6 months trends, the stock was at of +49.05% and +337.06%, respectively. Canadian Solar Inc., together with its subsidiaries, engages in the design, development, manufacture, and sale of solar power products worldwide. The company offers solar wafers, cells, and solar module products that convert sunlight into electricity for various uses. Its products include a range of standard solar modules for use in a range of residential, and industrial solar power generation systems.
Will CSIQ Continue To Move Higher? Find Out Here
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) enhanced +4.64% and its closing price was $1.58. The volume of the stock was 1.65 million shares and the average volume remained 193,573.00 shares. Yesterday, the stock traded amid the day price range of $1.57 - $1.82. The market capitalization of the stock remained 73.46 million. The beta of the stock remained 0.87. Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies.
Why Should Investors Buy ACUR After The Recent Gain? Just Go Here and Find Out
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) exchanged 1.62 million shares in the previous trading session, and its average trading remained 834,229.00 shares. IRWD dropped -4.82% and it closed the trading at $12.84. The market capitalization of the stock remained 1.88 billion. YTD trend of the stock was positive +17.47%. Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company?s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) gastrointestinal disorders under the LINZESS name in the United States and Constella name in the European Union.
Has IRWD Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)